Navigation Links
World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins
Date:12/9/2009

BOSTON, Dec. 9 /PRNewswire/ -- Brian Newman, MD, FRCS, will conduct two training sessions for medical professionals on the Veinwave(TM) system, a revolutionary system used by doctors around the world to non-invasively eliminate spider veins and telangiectasia.

Dr. Newman, an internationally-acclaimed vascular surgeon based in the United Kingdom, developed Veinwave(TM) as a safe, reliable, non-invasive treatment utilizing the principle of Unipolar Thermo-Coagulation (UTC). UTC utilizes proprietary technology to deliver the unique radio-frequency energy without the need for anesthesia. An independent six-year study from Georges Pompidou Hospital documents the safety and effectiveness of this proprietary system with no side effects.

The Advanced Training Session for vascular surgeons is by invitation only and will be held Friday, Dec. 11, at the CardioVascular Institute at Beth Israel Deaconess Medical Center. A second seminar is open to all physicians and is scheduled for Saturday, Dec. 12, 9 a.m. at the Boston Marriott Newton. The seminar will cover an overview of the Veinwave(TM) technology, review case studies and procedural techniques, and allow attendees to observe live patient treatments. There is no fee to attend, but space is limited. To register, contact Amy Easterly at (205) 427-9323.

The CardioVascular Institute (CVI) at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, is the first Boston health care organization to purchase the revolutionary Veinwave(TM) system. The CVI's vascular surgeons include Allen D. Hamdan, MD, Frank B. Pomposelli, MD, Marc Schermerhorn, MD, and Mark C. Wyers, MD. Patients may book appointments by contacting the CardioVascular Institute at the Lowry Medical Office Building, 110 Francis Street, Suite 5B, Boston, MA 02215 (617) 632-9959. For more information, visit www.bidmc.org/vascular.

About Dr. Brian Newman, MD, FRCS

Dr. Brian Newman, MD, FRCS, is the developer of Veinwave(TM), a revolutionary medical device used by doctors around the world to eliminate spider veins on the legs and fine thread veins, known as telangiectasia. A General and Vascular Consultant Surgeon based in the UK, Dr. Newman graduated in medicine from Manchester University in 1968. In 1973 he became a fellow of The Royal College of Surgeons and obtained his M.D. in 1977. Dr. Newman worked as an NHS consultant general surgeon at the Royal Bolton Hospital and a number of private hospitals in the North West of England.

Since the late 1990s, Dr Newman has concentrated his work on non-invasive procedures for telangiectasia and spider veins. In July 2001, the Veinwave(TM) was launched in the UK. Since then, Dr. Newman has trained hundreds of surgeons and today over 1,000 systems are used every day worldwide.

About Veinwave(TM)

The Veinwave(TM) is the world's most advanced treatment for effective removal of unwanted spider veins and telangiectasia. Used for nearly a decade by over 1,000 physicians in Europe, Veinwave(TM) recently received 510k clearance from the FDA to market in the USA. Designed primarily for vascular surgeons, dermatologists and plastic surgeons, Veinwave(TM) uses a revolutionary process called Unipolar Thermo-Coagulation (UTC), wherein a unique localized energy is applied to the skin on top of the affected area, causing the vein walls to collapse and the vein to disappear instantly.

Vein removal with the Veinwave(TM) provides safe, quick, and dramatic reduction of unwanted veins on any skin type, including ethnic and dark-skinned individuals. The technology significantly minimizes pain and the risks of bruising, burning, scaring and pigmentation changes that are associated with alternative treatments such as lasers and other light based systems. As a result, Veinwave(TM) has become the treatment of choice for practitioners and patients alike, providing a relatively painless walk-in/walk-out procedure with no bandages nor post-procedure care. Patients can resume regular activities and normal sun exposure immediately following treatment. For more information, visit www.VeinwaveUSA.com or call (205) 427-9323.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Dr. Brian Newman

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=92445

SOURCE Veinwave


'/>"/>
SOURCE Veinwave
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. World-Renowned Therapist Joins The Center for Children and Families In Its Work With the Nations Poorest Families
2. World-renowned bioengineers to record history of medical inventions
3. World-Renowned Scientists to Lead Immunology Course
4. World-Renowned Physicians Converge on Methodist Dallas Medical Center for Largest Live Demonstration of Its Kind in Texas
5. World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
6. World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8
7. World-Renowned Golf Instructor David Leadbetter Promotes VaNu
8. World-renowned neuroscientist visits UTSA on May 5 to discuss the quest for consciousness
9. World-Renowned Neuroscientist Dr. Candace Pert will be Featured Speaker at the Chopra Center's Signature Mind-Body Healing Workshop in San Diego
10. World-renowned nanotechnology expert proves there is big potential in the smallest of matter
11. Tickets on Sale Now for World-Renowned Bodies...The Exhibition At Mall of America(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: